FOLFOX in patients aged between 76 and 80 years with metastatic colorectal cancer
Arie Figer
Cancer, 2007
View PDFchevron_right
Comparative Effectiveness of Chemotherapy in Elderly Patients with Metastatic Colorectal Cancer
Carolina Reyes, Edward McKenna
Journal of Gastrointestinal Cancer, 2012
View PDFchevron_right
Oxaliplatin in Combination with 5-Fluorouracil/Leucovorin or Capecitabine in Elderly Patients with Metastatic Colorectal Cancer
A. Grothey, Axel Hinke
Clinical Colorectal Cancer, 2008
View PDFchevron_right
Safe Use of FOLFOX in Two Patients With Metastatic Colorectal Carcinoma and Severe Hepatic Dysfunction
Jhenee Bubenzer
Clinical Colorectal Cancer, 2011
View PDFchevron_right
Capecitabine plus oxaliplatin for the first-line treatment of elderly patients with metastatic colorectal carcinoma: Final results of the Southern Italy Cooperative Oncology Group Trial 0108
vito lorusso
Cancer, 2005
View PDFchevron_right
Toxicities and Survival Among Octogenarians and Nonagenarians with Colorectal Cancer Treated with Chemotherapy or Concurrent Chemoradiation Therapy
Marwan Fakih
Clinical Colorectal Cancer, 2007
View PDFchevron_right
Effects of newly developed chemotherapy regimens, comorbidities, chemotherapy-related toxicities on the changing patterns of the leading causes of death in elderly patients with colorectal cancer
Dejian Lai
Annals of Oncology, 2014
View PDFchevron_right
Clinical activity and tolerability of FOLFIRI and cetuximab in elderly patients with metastatic colorectal cancer in the CAPRI-GOIM first-line trial
Giuseppe Tonini
ESMO Open, 2017
View PDFchevron_right
The PANDA study: a randomized phase II study of first-line FOLFOX plus panitumumab versus 5FU plus panitumumab in RAS and BRAF wild-type elderly metastatic colorectal cancer patients
Francesca Battaglin
BMC cancer, 2018
View PDFchevron_right
Chemotherapy options in elderly and frail patients with metastatic colorectal cancer (MRC FOCUS2): an open-label, randomised factorial trial
Matthew Seymour
The Lancet, 2011
View PDFchevron_right
Effect of FOLFOX on minimal residual disease in Stage III colon cancer and risk of relapse
eghon guzman
ecancermedicalscience, 2019
View PDFchevron_right
Capecitabine Plus Oxaliplatin and Bevacizumab, Followed by Maintenance Treatment With Capecitabine and Bevacizumab for Patients Aged > 75 Years With Metastatic Colorectal Cancer
Edoardo Francini
Clinical Colorectal Cancer, 2018
View PDFchevron_right
Elderly patients with colorectal cancer: Treatment modalities and survival in France. National data from the ThInDiT cohort study
Philippe Ricordeau
European Journal of Cancer, 2014
View PDFchevron_right
First-Line Biological Agents Plus Chemotherapy in Older Patients with Metastatic Colorectal Cancer: A Retrospective Pooled Analysis
Alfredo Carrato
Drugs & Aging, 2021
View PDFchevron_right
Clinical outcome of elderly patients with metastatic colorectal cancer treated with FOLFOXIRI versus FOLFIRI: Subgroup analysis of a randomized phase III trial from the Hellenic Oncology Research Group (HORG)
A. Karampeazis, Athanasios Athanasiadis
Critical Reviews in Oncology/Hematology, 2010
View PDFchevron_right
A Phase II Study of Modified FOLFOX4 for Colorectal Cancer Patients with Peritoneal Carcinomatosis
Seok Jae Huh
Cancer Research and Treatment, 2011
View PDFchevron_right
Chemotherapy for older patients with colorectal cancer
Matthew Seymour
The Lancet, 2011
View PDFchevron_right
5-Fluorouracil–Based Chemotherapy for Advanced Colorectal Cancer in Elderly Patients: A North Central Cancer Treatment Group Study
Daniel Sargent
Clinical Colorectal Cancer, 2005
View PDFchevron_right
Metastatic colorectal cancer in the elderly: An overview of the systemic treatment modalities (Review)
Lubomir Bodnar
Oncology Letters, 2010
View PDFchevron_right
Front-line Bevacizumab in combination with Oxaliplatin, Leucovorin and 5-Fluorouracil (FOLFOX) in patients with metastatic colorectal cancer: a multicenter phase II study
Nikolaos Androulakis
BMC Cancer, 2007
View PDFchevron_right
Capecitabine plus oxaliplatin for the first-line treatment of elderly patients with metastatic colorectal carcinoma
Donato Natale
Cancer, 2005
View PDFchevron_right
Efficacy and Tolerability of Chemotherapy in Elderly Patients with Metastatic Gastric Cancer
Melih Simsek
Turkish Journal of Geriatrics-Turk Geriatri Dergisi, 2016
View PDFchevron_right
Do we know what to do with our nonagenarian and centenarian patients with metastatic colorectal cancer (mCRC)? Results from the South Australian mCRC registry
AMITESH Roy
Acta oncologica (Stockholm, Sweden), 2018
View PDFchevron_right
Efficacy of panitumumab in older patients with metastatic colorectal cancer: a retrospective analysis using the database of the Hellenic Oncology Research Group (HORG)
Nikolaos Kentepozidis
Journal of Geriatric Oncology, 2019
View PDFchevron_right
Chemotherapy in Elderly Patients with Metastatic Colorectal Cancer: Relations to Co-morbidities and Functional abilities
Loaie El-Helw
View PDFchevron_right
FOLFOX (oxaliplatin and 5fluorouracil/leucovorin) in patients with untreated metastatic gastric adenocarcinoma Phase II study
Mohammad Hassan
Indian Journal of Cancer, 2011
View PDFchevron_right
FOLFOX-4 Regimen as First-Line Chemotherapy in Elderly Patients with Advanced Gastric Cancer: A Safety Study
rocco giannicola
Journal of Chemotherapy, 2007
View PDFchevron_right
Palliative chemotherapy in elderly patients with metastatic colorectal cancer: Do we know how it should be used?
Theofanis Economopoulos
Acta Oncologica, 2012
View PDFchevron_right
Chemotherapy and Targeted Agents in the Treatment of Elderly Patients with Metastatic Colorectal Cancer
Mireia Gil Raga
Journal of Clinical Medicine
View PDFchevron_right
FOLFOX Alternated with FOLFIRI as First-Line Chemotherapy for Metastatic Colorectal Cancer
Jorge Aparicio
Clinical Colorectal Cancer, 2005
View PDFchevron_right
Feasibility and efficacy of capecitabine and FOLFIRI in patients aged 65 years and older with advanced colorectal cancer: a retrospective analysis
Lubomir Bodnar
Journal of Cancer Research and Clinical Oncology, 2010
View PDFchevron_right